ORIENT BIO Inc. (KRX:002630)

Market Cap	78.73B -54.4%
Revenue (ttm)	59.09B +19.5%
Net Income	-6.85B
EPS	-57.81
Shares Out	118.57M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,203,220
Average Volume	5,356,519
Open	686.00
Previous Close	680.00
Day's Range	651.00 - 692.00
52-Week Range	513.00 - 2,560.00
Beta	0.14
RSI	60.76
Earnings Date	n/a

About ORIENT BIO

ORIENT BIO Inc. operates in the bio-industry in South Korea and internationally. It engages in the production, export, import, and life science-related research and development of laboratory animals; and offers various equipment for research environment. The company also provides infrastructural solution; health checking; generic testing; molecular biological generic testing; generic transformation; phenotyping; preconditioning; surgical treatment; transgenic services; eggs and avian research; support services for husbandry tasks; diagnostic an...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1959
• Employees: 125
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 002630

Financial Performance

In fiscal year 2021, ORIENT BIO's revenue was 52.02 billion, an increase of 39.79% compared to the previous year's 37.21 billion. Losses were -15.63 billion, 30.3% more than in 2020.